Wipfler et al. Characteristics refractory RA. Associations at baseline (A) and follow-up (B) @RheumNow #ACR22 Abstr#1952 https://t.co/4PJtrDp3Ba https://t.co/x1NCq07Y1h

• Burden of Disease in Refractory Rheumatoid Arthritis - ACR Meeting Abstracts

Systemic Inflammation Index (neutrophils*platelet count/lymphocyte count) predicts survival in RA in 1000+ pts All cause mortality OR 2.64 CV-mortality OR 3.03 Another proof (if needed) of asso inflammation & mortality in RA https://t.co/A77iPTTfTM Abs#1650 #ACR22 @RheumNow https://t.co/8aHYAZEg6v

• Systemic Immune Inflammation Index Predict All-Cause and Cardiovascular Mortali…

Tuttle et al. Phase 2 RCT of Peresolimab (PD-1 stimulator) in DMARD-IR RA. Evidence of efficacy. No new safety signals @RheumNow #ACR22 Abstr#L03 https://t.co/vhrmtGTjw1 https://t.co/k1LLk95bv1

• A Phase 2 Trial of Peresolimab for Adults with Rheumatoid Arthritis - ACR Meeti…

Ozen et al. Safety Opioids vs NSAIDs in RA. Similar risks except 2-fold increase in VTE with opioids. @RheumNow #ACR22 Abstr#1646 https://t.co/kWBf8t4TFh https://t.co/dxKoilOhFX

• Major Adverse Cardiovascular Events and Mortality with Opioids versus NSAIDs In…

FORWARD databank RA 4500+ opioid & 11000+ NSAID MACE 133 vs. 392 (18.2/1000 PY vs. 14.6/1000 PY) Deaths 95 vs. 228 (12.6/1000 PY vs. 8.2/1000 PY) IR MACE & mortality NSAID < Opioids Driven by VTE > Opioids vs NSAIDs HR=2.45 https://t.co/fl7cJNGrvu Abs#1646 #ACR22 @Rheumnow https://t.co/wV5hYMfYLl

• Major Adverse Cardiovascular Events and Mortality with Opioids versus NSAIDs In…

Brooks et al. Risk lung cancer higher in RA (aHR 1.53) and RA-ILD (aHR 3.06) than controls. Persisted in non-smokers, non-RA-ILD, incident RA @RheumNow #ACR22 Abstr#1647 #ACRbest https://t.co/c18k9OLDIm https://t.co/UTgYZAmfmk

• Increased Risk of Lung Cancer in Rheumatoid Arthritis and Rheumatoid Arthritis-…

Juge @Juge_P_A @PhilippeDieude et al. Increased mortality in RA-ILD. HR 3.4 vs RA. <75 HR 4.8 . ILD first HR 8.4 @RheumNow #ACR22 Abstr#1959 #ACRbest https://t.co/mnbeBPuyC7 https://t.co/sLU2ZuTMw7

• Increased Mortality in Patients with RA-Associated Interstitial Lung Disease: D…

Paul Emery presenting phase 2 data Peresolimab in RA. Novel mechanism aiming to restore immune homeostasis. Exciting for rheumatic disease beyond RA. @RheumNow #ACR22 #LateBreaking https://t.co/oOjvo5YmDB

Tam et al . Increased CV risk in early RA abrogated with treat to target approach. @RheumNow #ACR22 Abstr#1649 https://t.co/i2iHyPoKf0 https://t.co/u0R00oolyP

• Five-Year Cardiovascular Event Risk in Early Rheumatoid Arthritis Patients Who …

Kimbrough et al. Comorbidities assoc serious infection in RA. Many! 26/55 comorbidities assoc serious infection. Number of comorbidities also assoc HR 1.16 (1.13-1.19) @RheumNow #ACR22 Abstr#1950 https://t.co/gnIlaJ037B https://t.co/6SR2Ej584w

• Morbidities Associated with Serious Infections in Patients with Rheumatoid Arth…

RA asso w/ higher risk of lung cancer aHR 1.53, also in non-smokers aHR 1.66 🚬 Now this risk increases even more in pts w/ RA-ILD 🫁 aHR 3.06 No adjustment on occupation or non tobacco inhaled toxic exposure https://t.co/41ibPD6S3b Abs#1647 #ACR22 @RheumNow https://t.co/LNw792MYV0

• Increased Risk of Lung Cancer in Rheumatoid Arthritis and Rheumatoid Arthritis-…

Lindegren et al. Dairy intake and RA risk in Sweden. Nested case-control. High regular milk intake assoc increased risk (OR 1.90) High cheese assoc decresaed risk (OR 0.52) @RheumNow #ACR22 Abstr#1758 https://t.co/jUz3SJBf4Y https://t.co/ZykW3NjSrK

• Intake of Dairy Products as a Risk Factor for Rheumatoid Arthritis; A Nested Ca…

A spicy result. say NO to turmeric in #rheumatoidarthritis Eat it on food, but don’t expect it to help your joints. @RheumNow #ACR22 https://t.co/1mZBm3rYAA

• https://twitter.com/drdavidliew/status/1592148453504737280

Lillegraven @SiriLillegraven ARCTIC REWIND. RA patients flare-free on half-dose csDMARD x 12 months - randomised to continue or stop. Flare 38% vs 17% over 12 months. DAS remission 96% vs 90%. Absence radiograph prog 84% vs 69% @RheumNow #ACR22 Abstr#2013 https://t.co/uOwd8Io5wZ https://t.co/SKWPE7GBrx

• Drug Free Remission in Rheumatoid Arthritis: Data from the Randomized Controlle…

NSAIDs and CV risk in Inflammatory Arthritis Dr. Richard Conway discusses abstract 1207, being presented #ACR22 meeting. https://t.co/CjU2YbA3tk https://t.co/bHE4xw2IRF

• https://bit.ly/3WZ6P6D